Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice

Abstract

Blood-cell morphology analysis is a cornerstone of hematological diagnostics, with implications spanning oncology, infectious diseases, and systemic disorders. Traditional manual assessment is labor-intensive and subject to interobserver variability. Recent advances in artificial intelligence (AI), particularly the development of foundation models trained on large, diverse blood-cell images, promise to revolutionize morphological interpretation. This review explores the epidemiology of hematological disorders, current diagnostic challenges, pathophysiological underpinnings of morphological changes, and the integration of foundation models into clinical workflows. Emphasis is placed on recent evidence, emerging therapies, and guideline-driven implications for practice, aiming to equip clinicians with a comprehensive understanding of this evolving domain.

Introduction

Blood-cell morphology assessment remains pivotal in diagnosing hematological and systemic diseases, guiding treatment decisions, and monitoring therapy response. However, the subjective nature and high resource demands of manual microscopy necessitate more robust, reproducible, and scalable solutions. Foundation models—large-scale AI systems pre-trained on vast datasets—have emerged as transformative tools in computational pathology. By capturing the complexity of blood-cell morphology, including subtle disease-specific features, these models hold potential to standardize diagnostics, reduce error rates, and enhance patient outcomes. This review synthesizes current evidence on blood-cell morphology foundation models, their clinical integration, and the implications for future hematopathology practice.

Epidemiology / Disease Burden

Hematological diseases, including anemias, leukemias, myelodysplastic syndromes, and infectious processes, collectively impose a significant global health burden. According to the World Health Organization, anemias affect over 1.6 billion people worldwide, while hematologic malignancies are among the leading causes of cancer-related mortality. Accurate morphological assessment is critical for early detection and classification, yet access to skilled morphologists remains limited, particularly in low-resource settings. Inconsistent diagnostic quality contributes to delayed or inappropriate therapy, further exacerbating morbidity and mortality. The increasing incidence of complex hematological presentations in aging populations underscores the need for scalable, high-fidelity diagnostic platforms such as foundation models.

Pathophysiology

Blood-cell morphology reflects dynamic physiological and pathological processes. Erythrocyte, leukocyte, and platelet abnormalities often correlate with underlying bone marrow pathology, genetic mutations, infectious agents, or systemic inflammation. For instance, anisopoikilocytosis and schistocytes may indicate microangiopathic hemolytic anemia, while dysplastic neutrophils suggest myelodysplasia. Malignant transformations, such as leukemic blasts, manifest distinct morphological signatures. Foundation models, through deep neural architectures, are capable of learning these complex feature representations, distinguishing subtle morphologic aberrations, and correlating them with specific pathophysiological states. This mechanistic understanding is critical for precise disease stratification and prognostication.

Risk Factors

Several risk factors contribute to the development and progression of blood-cell morphological abnormalities. Genetic predispositions (e.g., mutations in JAK2, TP53), environmental exposures (e.g., radiation, toxins), chronic infections (HIV, malaria), nutritional deficiencies (iron, vitamin B12, folate), and immunological disorders all influence hematopoiesis and cell structure. In clinical practice, recognizing these risk factors is essential for contextualizing morphological findings and guiding appropriate investigations. Foundation models, when integrated with electronic health record data, may further enhance risk stratification by correlating morphological anomalies with patient-specific risk profiles.

Clinical Features

Abnormal blood-cell morphology often manifests with non-specific clinical features such as fatigue, pallor, bleeding tendencies, recurrent infections, or organomegaly. In acute leukemias, blast proliferation leads to constitutional symptoms and cytopenias. In contrast, chronic anemias may present insidiously. Morphological patterns—such as spherocytes in hereditary spherocytosis or hypersegmented neutrophils in megaloblastic anemia—directly inform differential diagnosis. The clinical utility of foundation models lies in their ability to accurately and rapidly identify these pathognomonic features, supporting timely clinical decision-making and reducing diagnostic error.

Diagnosis

Definitive diagnosis of hematological disorders relies on comprehensive blood counts, peripheral smear evaluation, flow cytometry, molecular assays, and, when needed, bone marrow examination. Manual morphological interpretation is considered the gold standard but is challenged by subjectivity and limited reproducibility. Early AI-based approaches improved throughput but were constrained by narrow datasets and limited generalizability. Foundation models, trained on millions of annotated images, transcend these limitations, achieving expert-level performance across diverse populations and disease entities. Validation studies demonstrate high sensitivity and specificity in detecting abnormal morphologies, subclassifying leukemias, and flagging critical findings for pathologist review. Integration with laboratory information systems streamlines workflows and enables real-time decision support.

Treatment & Management

Accurate morphological diagnosis directly informs treatment strategies, from iron supplementation in deficiency anemias to targeted therapies in leukemias and myelodysplastic syndromes. Early identification of high-risk morphologies—such as blasts or dysplastic cells—triggers prompt intervention, improving prognosis. Foundation models facilitate rapid triage and prioritization of urgent cases, potentially reducing time to therapy initiation. Moreover, ongoing monitoring of morphological response to treatment enables dynamic therapy adjustments, supporting precision medicine approaches. As these models evolve, their integration with molecular and clinical data will further refine personalized management algorithms.

Recent Advances / Emerging Therapies

Recent years have seen a proliferation of research on foundation models for blood-cell morphology. Notable advances include self-supervised learning architectures, multimodal integration (combining images with clinical and genomic data), and models capable of continuous learning from real-world practice. These systems outperform traditional rule-based algorithms in recognizing rare morphologies and novel phenotypes. Emerging therapies, particularly in hematologic malignancies, are increasingly guided by morphological and molecular stratification, underscoring the clinical value of accurate, scalable diagnostics. Collaborative initiatives, such as open-source image repositories and standardized annotation protocols, are accelerating model development and validation across diverse populations.

Guideline Recommendations

Current international guidelines, including those from the World Health Organization and the College of American Pathologists, recognize the importance of digital pathology and AI-driven solutions in hematological diagnostics. While foundation models are not yet universally mandated, their deployment is encouraged in settings where access to expert morphologists is limited or where high-throughput workflows are required. Guidelines emphasize the need for rigorous validation, continuous quality assurance, and pathologist oversight. Future updates are expected to integrate specific recommendations for the implementation and governance of foundation models, reflecting their growing clinical impact.

Conclusion

Foundation models for blood-cell morphology represent a paradigm shift in hematological diagnostics, offering unprecedented accuracy, efficiency, and scalability. By automating and standardizing morphological interpretation, these models address longstanding challenges in diagnostic quality and access, with direct implications for patient care. Ongoing research, multidisciplinary collaboration, and alignment with clinical guidelines will be essential to fully realize their transformative potential. As these technologies mature, they are poised to become integral components of precision hematology and broader clinical decision-making frameworks.